Vanta Bioscience Ltd Peer Comparison
540729 · Healthcare · Current price
Peers tracked
16
Vanta Bioscience Ltd P/E
168.6x
Sector
Healthcare
Vanta Bioscience Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,837.3 | 39.1x | 4,40,918 |
| DIVI S LABORATORIES LTD | ₹9,375 | 69.1x | 2,48,886 |
| TORRENT PHARMACEUTICALS L | ₹4,840 | 72.9x | 1,63,850 |
| ZYDUS LIFESCIENCES LTD | ₹1,160 | 22.0x | 1,16,728 |
| CIPLA LTD | ₹1,394.5 | 30.3x | 1,12,634 |
| LAURUS LABS LIMITED | ₹1,954 | 92.8x | 1,05,391 |
| MAX HEALTHCARE INS LTD | ₹1,049.3 | 76.1x | 1,02,221 |
| AUROBINDO PHARMA LTD | ₹1,734 | 25.9x | 1,00,712 |
| DR. REDDY S LABORATORIES | ₹1,185 | 26.8x | 98,904 |
| LUPIN LIMITED | ₹2,083 | 20.6x | 95,235 |
| MANKIND PHARMA LIMITED | ₹2,300.7 | 53.7x | 94,992 |
| MANIPAL HEALTH ENTERPRI L | ₹738.95 | 106.4x | 94,201 |
Vanta Bioscience Ltd versus its peers
Vanta Bioscience Ltd operates in the Healthcare space alongside 16 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 168.6x may be cheap in one industry and expensive in another.
More on Vanta Bioscience Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.